Table 2:
Overall Survival | Disease-specific Survival | |||||
---|---|---|---|---|---|---|
Variable | Hazard Ratio | 95% CI | p value | Hazard Ratio | 95% CI | p value |
Age | 1.04 | 1.03–1.05 | <0.0001 | 1.01 | 1.00–1.02 | 0.165 |
Gender | 0.027 | 1.265 | ||||
Male | 1.00 (ref) | 1.00 (ref) | ||||
Female | 0.83 | 0.71–0.98 | 0.99 | 0.79–1.27 | ||
Race | 0.113 | 0.031 | ||||
White | 1.00 (ref) | 1.00 (ref) | ||||
Hispanic | 1.18 | 0.96–1.45 | 1.38 | 1.03–1.84 | ||
Any Renal Disease | 0.67 | 0.44–1.02 | 0.063 | 1.38 | 0.50–3.77 | 0.533 |
Diabetes | 0.68 | 0.56–0.82 | <0.0001 | 1.03 | 0.76–1.40 | 0.853 |
Tumor size (cm) | 1.04 | 1.027–1.047 | <0.0001 | 1.05 | 1.04–1.06 | <0.0001 |
Tumor Grade | <0.0001 | <0.0001 | ||||
Grade 1 | 0.45 | 0.33–0.62 | <0.0001 | 0.25 | 0.16–0.40 | <0.0001 |
Grade 2 | 0.4 | 0.31–0.51 | <0.0001 | 0.26 | 0.19–0.36 | <0.0001 |
Grade 3 | 0.53 | 0.41–0.68 | <0.0001 | 0.55 | 0.41–0.73 | <0.0001 |
Grade 4 | 1.00 (ref) | 1.00 (ref) | ||||
Histological Subtype | 0.364 | |||||
Clear Cell | 1.00 (ref) | 1.00 (ref) | ||||
Papillary | 0.92 | 0.62–1.38 | 0.695 | 0.9 | 0.42–1.92 | 0.78 |
Others | 0.89 | 0.70–1.12 | 0.326 | 0.81 | 0.58–1.12 | 0.199 |
AJCC Stage | <0.0001 | <0.0001 | ||||
Stage 1 & 2 | 1.00 (ref) | 1.00 (ref) | ||||
Stage 3 & 4 | 2.69 | 2.30–3.14 | 7.65 | 5.88–9.96 | ||
Treatment Status | <0.0001 | <0.0001 | ||||
Surgery | 1.00 (ref) | 1.00 (ref) | ||||
No Surgery | 3.79 | 2.95–4.88 | 5.74 | 4.23–7.81 | <0.0001 |